test

Adam Koppel

@Bain Capital Life Sciences Investors, Llc

Latest period2024 - Q3ReportedManaged Assets$961.176MTotal holdings24
Assets growth rate5.53%Assets growth rate (2-Q avg)-10.63%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Bain Capital Life Sciences Investors, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 24 positions.

Assets under management

The assets under management (AUM) of Bain Capital Life Sciences Investors, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 961.176M in assets, with a quarterly growth rate of 5.53% and a 2-quarter average growth rate of -10.63%. The portfolio is managed by Adam Koppel, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MRSNMersana Therapeutics Inc
Recent Activity
1.71%
$16.374M
8.664M shares@ $1.9 avg price
CABACabaletta Bio Inc
Recent Activity
Increased 67.34%
1.36%
$13.031M
2.761M shares@ $4.72 avg price
XFORX4 Pharmaceuticals Inc
Recent Activity
1.18%
$11.322M
16.916M shares@ $0.67 avg price
IPSCCentury Therapeutics Inc
Recent Activity
0.97%
$9.252M
5.41M shares@ $1.71 avg price
AVIRAtea Pharmaceuticals Inc
Recent Activity
0.87%
$8.327M
2.486M shares@ $3.35 avg price
CDTXCidara Therapeutics Inc
Recent Activity
New Position
0.79%
$7.558M
703,080 shares@ $10.75 avg price
RPIDRapid Micro Biosystems Inc
Recent Activity
0.79%
$7.507M
8.435M shares@ $0.89 avg price
CCCCC4 Therapeutics Inc
Recent Activity
0.66%
$6.338M
1.112M shares@ $5.7 avg price
SYRSSyros Pharmaceuticals Inc
Recent Activity
Increased 0.02%
0.62%
$5.913M
2.75M shares@ $2.16 avg price
NAUTNautilus Biotechnology Inc
Recent Activity
0.6%
$5.7M
2M shares@ $2.85 avg price